A landmark 2023 New England Journal of Medicine trial found that semaglutide significantly reduced the risk of major adverse cardiovascular events among adults with overweight or obesity, even in the absence of diabetes (NEJM, 2023)
Caucasian subjects were on average taller and weighed more than their Japanese counterparts (73.0 versus 63.6 kg, respectively)
WELLNESSPHARMACY.COM MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, AS TO THE OPERATION OF THIS SITE OR THE INFORMATION, CONTENT, MATERIALS, OR PRODUCTS INCLUDED ON THIS SITE
The FDA approved Ozempic for Type 2 diabetes management in 2017
Tapering Off of GLP-1s: A Gentle Exit Lowering your dose in small steps (from 2.4 mg of semaglutide to 1.7 mg, then to 1.0 mg) allows your hunger hormones and metabolism to adjust gradually to the changes in your body and brain
Allergic Reactions: Although rare, allergic reactions can occur with both medications